PAVmed Inc.
PAVM· Nasdaq
Released Apr 14, 2020, after the close
10-K filed Apr 14, 2020, 105 days after period end · 0001493152-20-006405
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$6.24M | -$6.83M | $869.84K | -$1.71M |
| EPS Diluted | — | — | — | -$0.13 |
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.